818
Participants
Start Date
September 26, 2011
Primary Completion Date
November 19, 2019
Study Completion Date
November 22, 2019
Magnesium Sulfate Sandoz
Each treatment will utilize 600 mg (1.2 mL) of Magnesium Sulfate Sandoz
Sodium Chloride , USP PPC
Intervention: The control group will receive Sodium Chloride , USP PPC (1.2 mL hypertonic 5.5% saline with 5 mg Salbutamol - GlaxoSmithKline/Pharmascience
Alberta Children's Hospital, Calgary
Stollery Hospital, Edmonton
BC Children's Hospital, Vancouver
The Manitoba Institute of Child Health, Winnipeg
Children's Hospital of Eastern Ontario, Ottawa
The Hospital for Sick Children, Toronto
Ste Justine Hospital, Montreal
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Alberta Children's Hospital
OTHER
St. Justine's Hospital
OTHER
Children's Hospital of Eastern Ontario
OTHER
Stollery Children's Hospital
OTHER
The Children's Hospital of Winnipeg
OTHER
Provincial Health Services Authority
OTHER
The Hospital for Sick Children
OTHER